Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  becatecarin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067548, U01CA062487, P30CA022453, WSU-C-2063, NCI-T99-0113, T99-0113, NCT00005027
Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000067695, AECM-T99-0109, NCI-T99-0109, T99-0109, NCT00005085
Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00031, 99-283, U01CA062502, CDR0000067821, DFCI-99283, CWRU-DFCI-1199, NCI-197, 197, NCT00005817
Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CWRU1599, U01CA063200, P30CA043703, NCI-91, 91, NCT00006017
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under at original diagnosis
Sponsor: NCI
Protocol IDs: NCI-2012-01851, COG-P9963, CDR0000068111, P9963, NCT00006102
Phase I Study of a Rebeccamycin Analogue in Patients With Metastatic Epithelial and Mesenchymal Tumors and Malignant Lymphomas (Summary Last Modified 06/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9493, NCI-T94-0118H, T94-0118
Phase I Study of a Rebeccamycin Analogue Bolus Infusion for Advanced Malignancies
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UTHSC-9455011077, SACI-IDD-94-32, NCI-T94-0136D, T94-0136
Phase I Study of Rebeccamycin Analogue (NSC #655649) in Children with Refractory Malignant Solid Tumors (Summary Last Modified 07/2002)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9670
Phase I Clinical and Pharmacokinetic Study of Rebeccamycin Analogue in Patients with Refractory or Recurrent Adult Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CWRU-4Y96, NCI-T97-0002, T97-0002
Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000067430, UTHSC-IDD-98-34, SACI-IDD-98-34, NCI-T98-0069, T98-0069, NCT00004189
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02609, MDA-2003-0909, U01CA062461, CDR0000373813, NCI-5651, 5651, NCT00087204
Start Over